Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $1.1 billion.

  • Madrigal Pharmaceuticals' Cash & Current Investments rose 1112.75% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1112.75%. This contributed to the annual value of $926.3 million for FY2024, which is 4606.62% up from last year.
  • As of Q3 2025, Madrigal Pharmaceuticals' Cash & Current Investments stood at $1.1 billion, which was up 1112.75% from $797.0 million recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Cash & Current Investments ranged from a high of $1.1 billion in Q3 2025 and a low of $153.2 million during Q3 2022
  • Its 5-year average for Cash & Current Investments is $549.0 million, with a median of $329.5 million in 2023.
  • As far as peak fluctuations go, Madrigal Pharmaceuticals' Cash & Current Investments plummeted by 4878.99% in 2022, and later surged by 32979.24% in 2024.
  • Over the past 5 years, Madrigal Pharmaceuticals' Cash & Current Investments (Quarter) stood at $270.3 million in 2021, then surged by 32.71% to $358.8 million in 2022, then soared by 76.75% to $634.1 million in 2023, then skyrocketed by 46.07% to $926.3 million in 2024, then rose by 19.81% to $1.1 billion in 2025.
  • Its Cash & Current Investments was $1.1 billion in Q3 2025, compared to $797.0 million in Q2 2025 and $843.1 million in Q1 2025.